Meixi Jiang

633 total citations · 2 hit papers
7 papers, 319 citations indexed

About

Meixi Jiang is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Meixi Jiang has authored 7 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Meixi Jiang's work include Extracellular vesicles in disease (3 papers), Phagocytosis and Immune Regulation (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Meixi Jiang is often cited by papers focused on Extracellular vesicles in disease (3 papers), Phagocytosis and Immune Regulation (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Meixi Jiang collaborates with scholars based in China and Taiwan. Meixi Jiang's co-authors include Bo Zhang, Haijing Wu, Bowen Li, Bo Wu, Xiang Shi, Hongxu Liu, Bo Wu, Bo Wu, Qian Wang and Bowen Li and has published in prestigious journals such as Molecular Cancer, Carcinogenesis and Signal Transduction and Targeted Therapy.

In The Last Decade

Meixi Jiang

6 papers receiving 317 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cold and hot tumors: from molecular mechanisms to targeted therapy

2024 174 citations Bo Wu, Bo Zhang et al. Signal Transduction and Targeted Therapy profile →
Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment

2023 113 citations Bo Wu, Xiang Shi et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Meixi Jiang China	5	140	125	104	62	53	7	319
Yanghong Ni China	8	140 1.0×	148 1.2×	108 1.0×	67 1.1×	34 0.6×	9	328
Barbara Montico Italy	10	146 1.0×	129 1.0×	166 1.6×	52 0.8×	37 0.7×	19	345
Zhitong Niu China	5	138 1.0×	191 1.5×	98 0.9×	93 1.5×	32 0.6×	6	331
Betül Gök Yavuz United States	6	172 1.2×	120 1.0×	137 1.3×	69 1.1×	34 0.6×	12	325
Benjamin Bian France	5	149 1.1×	133 1.1×	60 0.6×	77 1.2×	38 0.7×	6	296
Annunziata Nigro Italy	7	136 1.0×	100 0.8×	172 1.7×	34 0.5×	52 1.0×	11	316
Guillermo O. Rangel Rivera United States	10	185 1.3×	117 0.9×	169 1.6×	46 0.7×	38 0.7×	18	337
Shahrokh Abdolahi Iran	7	156 1.1×	95 0.8×	75 0.7×	71 1.1×	29 0.5×	13	311
Mukulika Bose United States	8	117 0.8×	143 1.1×	83 0.8×	31 0.5×	37 0.7×	13	260
Mei Feng China	10	158 1.1×	174 1.4×	121 1.2×	67 1.1×	35 0.7×	17	371

Countries citing papers authored by Meixi Jiang

Since Specialization

Citations

This map shows the geographic impact of Meixi Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meixi Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meixi Jiang more than expected).

Fields of papers citing papers by Meixi Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meixi Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meixi Jiang. The network helps show where Meixi Jiang may publish in the future.

Co-authorship network of co-authors of Meixi Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Meixi Jiang. A scholar is included among the top collaborators of Meixi Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meixi Jiang. Meixi Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Jiang, Meixi, Jingjing Qiu, Aibin He, et al.. (2025). Engineering TME-activated CD47-specific CAR macrophage via Arg1 promoter for safe and effective solid tumor immunotherapy. Journal for ImmunoTherapy of Cancer. 13(11). e012463–e012463.

2.

Wu, Bo, Bo Zhang, Bowen Li, Haijing Wu, & Meixi Jiang. (2024). Cold and hot tumors: from molecular mechanisms to targeted therapy. Signal Transduction and Targeted Therapy. 9(1). 274–274. 174 indexed citations breakdown →

3.

Wu, Bo, Xiaoni Zhan, & Meixi Jiang. (2024). CD58 defines regulatory macrophages within the tumor microenvironment. Communications Biology. 7(1). 1025–1025. 1 indexed citations

4.

Wu, Bo, Xiang Shi, Meixi Jiang, & Hongxu Liu. (2023). Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment. Molecular Cancer. 22(1). 38–38. 113 indexed citations breakdown →

5.

Wu, Bo, Qian Wang, Xiang Shi, & Meixi Jiang. (2022). Targeting Endocytosis and Cell Communications in the Tumor Immune Microenvironment. Cell Communication and Signaling. 20(1). 161–161. 12 indexed citations

6.

Liu, Lu, Jinlan Gao, Meixi Jiang, et al.. (2022). Cyclin G2 in macrophages triggers CTL-mediated antitumor immunity and antiangiogenesis via interferon-gamma. Journal of Experimental & Clinical Cancer Research. 41(1). 358–358. 10 indexed citations

7.

Wu, Bo, Qian Wang, Bowen Li, & Meixi Jiang. (2022). LAMTOR1 degrades MHC-II via the endocytic in hepatocellular carcinoma. Carcinogenesis. 43(11). 1059–1070. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact